Decreased expression of MT1E is a potential biomarker of prostate cancer progression

Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR) of the disease. Microarray-based gene expression profil...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Demidenko, Rita, Daniunaite, Kristina, Bakavicius, Arnas, Sabaliauskaite, Rasa, Skeberdyte, Aiste, Petroska, Donatas, Laurinavicius, Arvydas, Jankevicius, Feliksas, Lazutka, Juozas R., Jarmalaite, Sonata
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617458/
https://ncbi.nlm.nih.gov/pubmed/28977898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18683
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires